|
Profile Hunan Chemapi Biological Technology Co., Ltd. is a professional technology co***ny that engages in researching, developing and manufacturing APIs and intermediates. It was recognized as a high-tech enterprise in 2017, and a small giant of technological innovation in Changsha.The co***ny is founded by senior engineers and engineer teams with rich experience in chemical and pharmaceutical industries and it mainly engages in researching, developing, manufacturing and marketing APIs, pharmaceutical intermediates, and fine chemicals, and in import and export business in related fields. The co***ny is situated in Changsha City, Hunan Province, China. Based on perfect laboratory in Changsha City, pilot and tonnage-class production base in Yueyang City, and cooperation relations with a large number of well-known pharmaceutical enterprises in China, the co***ny is capable of preparing products from gram grade to ton grade efficiently. Chemapi has abundant experience in researching, developing and manufacturing antitumor drugs, antipsychotics, carbapenem drugs, steride drugs, and pharmaceutical intermediates with strong competitive power in aspects of technology and quality. Hunan Chemapi Biological Technology Co., Ltd. would like to cooperate with clients for achieving continuous fast development based on tenet of honest operation and mutual benefit. Main products are temozolomide and its intermediate, meropenem and its intermediate, ertapenem and its intermediate, biapenem and its intermediate. The output of temozolomide is 3-5T/A,AICA is 18T/A; biapenem is 1-2T/A; meropenem side chain is 10-15T/month. Office address£º7-3105 Vanke Jinyuhuafu ,Wanjiali Road, Yuhua District, Changsha City, Hunan Province, China Factory address: Yunxi Industrial Park, Yueyang, Hunan Tel£º0731-89714511£»0730-8426189
|
Company: |
Hunan Chemapi Biological Technology Co.,Ltd.
|
Contact: |
Mr. Fan Rong |
Address: |
Yunxi Industrial Park, Yueyang, Hunan |
Postcode: |
410001 |
Tel: |
86 13972595635 |
Fax: |
86 0731 89714511 |
E-mail: |
|
|
|
|